Five Stocks Trading Higher Amid Positive News
Major indices are showing marginal gains as Allergan plc Ordinary Shares (NYSE:AGN) announced its acquisition of Vitae Pharmaceuticals Inc (NASDAQ:VTAE), while Mattress Firm Holding Corp (NASDAQ:MFRM...
Vitae Pharmaceuticals Inc (VTAE)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Stevens Capital Management Matthew Tewksbury | 0 | $0 | 0% | |
| 2. | TIG Advisors Carl Tiedemann And Michael Tiedemann | 0 | $0 | 0% | |
| 3. | Overland Advisors Gordy Holterman And Derek Dunn | 0 | $0 | 0% | |
| 4. | DAFNA Capital Management Nathan Fischel | 0 | $0 | 0% | |
| 5. | Baker Bros. Advisors Julian Baker And Felix Baker | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.83 | 10,000 | Officer | 10,000 | 2015-08-27 | Filing | |
| $8.00 | 671,807 | Large Shareholder | 2,572,523 | 2014-09-29 | Filing | |
| $8.00 | 813,474 | Large Shareholder | 2,611,564 | 2014-09-29 | Filing | |
| $8.00 | 15,446 | Large Shareholder, Director | 47,077 | 2014-09-29 | Filing | |
| $8.00 | 617,868 | Large Shareholder, Director | 1,883,372 | 2014-09-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.81 | 50,000 | Officer, Director | 244,996 | 2016-09-14 | Filing | |
| $20.85 | 1,025,000 | Large Shareholder | 2,375,000 | 2016-09-14 | Filing | |
| $7.42 | 16,130 | Director | 0 | 2016-03-21 | Filing | |
| $18.00 | 16,130 | Director | 0 | 2015-12-29 | Filing | |
| $17.00 | 22,524 | Officer, Director | 267,360 | 2015-12-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Vitae Pharmaceuticals Inc (VTAE): RA Capital Management Ups Its Stake
A recent 13G filing with the SEC revealed that Peter Kolchinsky's RA Capital Management has acquired more shares of Vitae Pharmaceuticals Inc (NASDAQ:VTAE), as it currently holds 2.12 million common...
Latest Smart Money Moves Involve Wells Fargo & Co (WFC), Qlik Technologies Inc. (QLIK) & More
Hedge fund closures reached the highest rate in 2015 since the financial crisis, according to fresh statistics.
What Is Driving The Growth of These Five Stocks on Thursday?
At a time when all three indices are in the green after the Fed concluded a two-day meeting without changing interest rates -as expected- and projecting fewer rate increases in the coming months (two ...
Why These 5 Stocks Tumbled As Markets Surged Today
After closing up marginally on Thursday, the markets are now surging today, with all major U.S stock indexes registering gains of 0.4%-to-0.5%. However, a few stocks are seeing marked declines.
Is Viate Pharmaceuticals Inc (VTAE) A Good Stock To Buy?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Adage Capital, P2 Capital Raise Their Antes On Vitae Pharmaceuticals Inc (VTAE), Forrester Research Inc. (FORR)
Phil Gross (pictured) and Robert Atchinson's Adage Capital Management recently added about 98,900 shares to its Vitae Pharmaceuticals Inc (NASDAQ:VTAE) holding, which now stands at 1.12 million shares...
Should You Follow Hedge Fund Sentiment Of Wednesday’s Top 3 Healthcare Gainers?
As we have covered the top losers among healthcare stocks earlier today, which included three biotech companies, it's time to take a look at some companies that have been gaining ground.
Hedge Funds Stung By Plunging Vitae Pharmaceuticals Inc (VTAE)
Vitae Pharmaceuticals Inc (NASDAQ:VTAE) may have seemed to be a very good bet for hedge funds by the end of the first quarter, but the stock plunged over 40% from its closing price of $15.19 per share...
Billionaire Hedge Funds
